BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, December 8, 2025
See today's BioWorld
See today's BioWorld MedTech
Home
» Deadline nears with no consensus on broader WTO COVID-19 waiver
To read the full article
sign up for free
or
sign in
.
Deadline nears with no consensus on broader WTO COVID-19 waiver
Feb. 20, 2024
By
Mari Serebrov
Unless there’s a last-minute meeting of the minds, it looks like any extension of the World Trade Organization’s (WTO) five-year intellectual property waiver for COVID-19 vaccines will be shelved, at least for now.
BioWorld
BioWorld MedTech
Drugs
Regulatory
Coronavirus
Vaccine
Diagnostics
Medical devices